可药性
G蛋白偶联受体
变构调节
受体
生物
胰高血糖素受体
药物发现
计算生物学
胰高血糖素
胰岛素
生物信息学
生物化学
内分泌学
基因
作者
Raphael Alhadeff,Arieh Warshel
出处
期刊:Proteins
[Wiley]
日期:2019-07-11
卷期号:88 (1): 127-134
被引量:16
摘要
Abstract G‐protein‐coupled receptors (GPCRs) are among the most important receptors in human physiology and pathology. They serve as master regulators of numerous key processes and are involved in as well as cause debilitating diseases. Consequently, GPCRs are among the most attractive targets for drug design and pharmaceutical interventions (>30% of drugs on the market). The glucagon‐like peptide 1 (GLP‐1) hormone receptor GLP1R is closely involved in insulin secretion by pancreatic β‐cells and constitutes a major druggable target for the development of anti‐diabetes and obesity agents. GLP1R structure was recently solved, with ligands, allosteric modulators and as part of a complex with its cognate G protein. However, the translation of this structural data into structure/function understanding remains limited. The current study functionally characterizes GLP1R with special emphasis on ligand and cellular partner binding interactions and presents a free‐energy landscape as well as a functional model of the activation cycle of GLP1R. Our results should facilitate a deeper understanding of the molecular mechanism underlying GLP1R activation, forming a basis for improved development of targeted therapeutics for diabetes and related disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI